The Bill & Melinda Gates Foundation has committed $40 million in equity investment and $10 million in grant funding to Vir Biotechnology for the development of therapies against HIV and Malaria, Vir announced Friday. Read the full Press Release here.
Vir Biotechnology is a newly-formed company based in San Francisco focused on finding innovative solutions to unmet needs in infectious disease.
Ustar Technologies is a diagnostics company developing a tuberculosis diagnostic to increase prevention against one of the leading causes of death worldwide.
Vir Biotechnology January 6, 2017 Vir Biotechnology, Inc. today announced it is launching to develop cures, treatments, and preventions for challenging infectious diseases, with former Biogen CEO George Scangos heading a team of scientific and industry leaders. The company will be headquartered Read More
By Matthew Herper January 6, 2017 Most drug companies are retreating from the business of creating drugs against viruses and, especially, bacteria. But a well-funded startup being announced today is taking the challenge head-on. The new company, called Vir Biotechnology, Read More